Cell‐penetrating peptide conjugates of indole‐3‐acetic acid‐based DNA primase/Gyrase inhibitors as potent anti‐tubercular agents against planktonic and biofilm culture of Mycobacterium smegmatis. (23rd July 2021)
- Record Type:
- Journal Article
- Title:
- Cell‐penetrating peptide conjugates of indole‐3‐acetic acid‐based DNA primase/Gyrase inhibitors as potent anti‐tubercular agents against planktonic and biofilm culture of Mycobacterium smegmatis. (23rd July 2021)
- Main Title:
- Cell‐penetrating peptide conjugates of indole‐3‐acetic acid‐based DNA primase/Gyrase inhibitors as potent anti‐tubercular agents against planktonic and biofilm culture of Mycobacterium smegmatis
- Authors:
- Dewangan, Rikeshwer Prasad
Singh, Meenakshi
Ilic, Stefan
Tam, Benjamin
Akabayov, Barak - Abstract:
- Abstract: Mycobacterium tuberculosis ( Mtb ) is a pathogenic bacterium that caused 1.5 million fatalities globally in 2018. New strains of Mtb resistant to all known classes of antibiotics pose a global healthcare problem. In this work, we have conjugated novel indole‐3‐acetic acid‐based DNA primase/gyrase inhibitor with cell‐penetrating peptide via cleavable and non‐cleavable bonds. For non‐cleavable linkage, inhibitor was conjugated with peptide via an amide bond to the N‐terminus, whereas a cleavable linkage was obtained by conjugating the inhibitor through a disulfide bond. We performed the conjugation of the inhibitor either directly on a solid surface or by using solution‐phase chemistry. M. smegmatis (non‐pathogenic model of Mtb ) was used to determine the minimal inhibitory concentration (MIC) of the synthetic conjugates. Conjugates were found more active as compared to free inhibitor molecules. Strikingly, the conjugate also impairs the development of biofilm, showing a therapeutic potential against infections caused by both planktonic and sessile forms of mycobacterium species. Abstract : We conjugated novel indole‐3‐acetic acid‐based DNA primase/gyrase inhibitor with cell‐penetrating peptide. The conjugates were more active as compared to the free small‐molecule inhibitor and also impaired the development of M. smegmatis biofilm.
- Is Part Of:
- Chemical biology & drug design. Volume 98:Number 5(2021)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 98:Number 5(2021)
- Issue Display:
- Volume 98, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 98
- Issue:
- 5
- Issue Sort Value:
- 2021-0098-0005-0000
- Page Start:
- 722
- Page End:
- 732
- Publication Date:
- 2021-07-23
- Subjects:
- cell‐penetrating peptides -- DNA primase -- drug resistance -- gyrase inhibitors -- M. smegmatis -- M. tuberculosis
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.13925 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19930.xml